AbCellera Biologics (ABCL) Stock Highlights

2.75 | +0.73%

2024-09-19 03:44:59

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The companys AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Statistics

Range Today

2.71 2.92

Volume Today 1.89M

Range 1 Year

2.34 6.05

Volume 1 Year 400.82M

Range 3 Year

2.34 22.09

Volume 3 Year 1.47B

Range 10 Year

2.34 71.91

Volume 10 Year 1.79B

Highlights

Market Capitalization 810.33M (small)

Floating Shares 189.4M

Current Price 2.75

Price To Earnings -5.15

Price To Revenue 5.79

Price To Book 0.73

Earnings Per Share -0.53

Payout Ratio 0%

Performance

Latest +0.73%

1 Month +4.56%

3 Months -11.29%

6 Months -42.47%

1 Year -48.41%

3 Years -85.8%

5 Years -95.49%

10 Years -95.49%

Benchmarks

Market Capitalization

98 / 368

Gross Profits

21 / 278

Total Revenue

120 / 300

Total Rank

255 / 368

Free Cashflow

242 / 352

Performance 5 years

334 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.